6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
23m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
56m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
56m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
56m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
56m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Kiora Pharmaceuticals Inc (NASDAQ:KPRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway

Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline

Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors

Kiora Pharmaceuticals Announces Management Team Changes

Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials

Financials

Revenue

$0

Market Cap

$7.66 M

EPS

-2.64

Community Chat

Ask AI